tert-Butyl (R)-3-(6-(dibenzylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)pyrrolidine-1-carboxylate

Catalog No. :
ACAYTI928
CAS No. :
1439901-93-5
Molecular Formula :
C28H32N6O3
Molecular Weight :
500.60

IUPAC Name:tert-butyl (R)-3-(6-(dibenzylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)pyrrolidine-1-carboxylate

tert-Butyl (R)-3-(6-(dibenzylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$552.00Login to see priceInquiryInquiry
1g98%$1218.00Login to see priceInquiryInquiry
5g98%$4019.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (R)-3-(6-(dibenzylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl (R)-3-(6-(dibenzylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)pyrrolidine-1-carboxylate
MDL No.-
Molecular FormulaC28H32N6O3
Molecular Weight500.60
SMILESO=C1NC2=C(N(CC3=CC=CC=C3)CC4=CC=CC=C4)N=CN=C2N1[C@H]5CN(C(OC(C)(C)C)=O)CC5
InChI KeyFMJRVNWBIFUYFR-JOCHJYFZSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-[6-[bis(phenylmethyl)amino]-7,8-dihydro-8-oxo-9H-purin-9-yl]-, 1,1-dimethylethyl ester, (3R)-;(R)-9-(1-Boc-3-pyrrolidinyl)-6-(dibenzylamino)-7H-purin-8(9H)-one
CAS No.1439901-93-5

Synthetic Route by SureRoute

1. ACAYTI928 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAYTI928 route product structure diagram
    ACAYTI9281439901-93-5
Inquiry

2. ACAYTI928 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAYTI928 route product structure diagram
    ACAYTI9281439901-93-5
Inquiry

Comments (0)